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Abstract
Background. Complementary therapies (CTs) are increasingly utilized by cancer patients. Nonetheless, patients report
insufficient support from health care practitioners (HCPs) and there is a general lack of patient-practitioner communication
about CT use. Best care practices suggest that HCPs should address the needs of patients, including CT use. This study
examined current practices of patients and HCPs as well as their interactions relating to CTs. Methods. A total of 481
cancer outpatients and 100 HCPs completed questionnaires. Patient questions addressed CT use and information needs;
HCP questions addressed knowledge, opinions and beliefs about complementary and alternative medicine. Patientpractitioner communication around CT was also examined. Results. 47% of patients reported using CTs since diagnosis.
Many commenced CT use to improve quality of life (65%) based on recommendations from family or friends. Patients
acknowledged the need for trusted sources of information and would attend a hospital-based education program (72%).
HCPs reported limited training about CTs but most (90%) expressed interested in receiving more training. The majority of
HCPs (>80%) reported limited knowledge about the role of CTs in cancer care or evidence to support CT use. Questions
about communication and interactions revealed that 80% of patients reported not having had an HCP speak to them
about CTs. However, 63% of HCPs reported addressing CT use. Conclusion. Results demonstrate a need for improved CT
education and training for patients and HCPs. increasing HCP knowledge and clinical skills will ensure patients’ information
needs about CTs are acknowledged and attended to, thereby providing safer and comprehensive cancer care.
Keywords
complementary therapies, cancer, integrative oncology, health care provider, alternative medicine

Introduction
Cancer is the leading cause of death in Canada, accounting
for approximately 30% of all mortalities.1 Along with
increasing cancer incidence and prevalence in Canada,2 survival rates are increasing due to enhanced screening and
better treatment.3 This has resulted in a large cohort of people termed “cancer survivors.”4 To enhance quality of life
and cope with treatment toxicities, many cancer survivors
look beyond conventional medicine and are turning to complementary and alternative medicine (CAM).5
CAM is defined by the National Center for Complementary
and Integrative Health (NCCIH) as “a group of diverse medical and health care systems, practices, and products that are
not generally considered part of conventional medicine.”6
CAM is a broad umbrella term for several categories

including natural health products, mind–body medicine,
manipulative and body-based practices, energy therapy, and
whole medical systems (eg, naturopathy).6 It includes both
complementary and alternative therapies, 2 distinct forms of
treatment. Complementary therapies (CTs) are used in
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addition to standard treatment, whereas alternative therapies
are used instead of conventional medicine.6
A recent meta-analysis found that 45% of all cancer
patients worldwide have used CAM since their diagnoses.5
CAM is most popular with females, breast cancer patients,
younger individuals, and those with a higher level of education and higher socioeconomic status.7-9
Despite the high use of CAM by cancer patients and a
preference to receive CAM information from credible
sources,10 patients list support groups, friends, family, and
books as their primary sources of CAM information.11,12
This presents a problem as patients may be receiving unreliable information and are often overwhelmed and confused
about the credibility of CAM information available.10
Additionally, it has been reported that up to 77% of cancer
patients do not disclose their CAM use to their HCP, demonstrating a lack of patient–practitioner communication
about CAM.13 This lack of communication is concerning
given the potential for CAM to exacerbate or alleviate
symptoms related to conventional treatments, as well as the
risk of interaction with conventional medications.14
HCPs have a responsibility to provide optimal care for
their patients and this should include addressing the risks
and benefits of CAM. Indeed, many patients assume that
HCPs will do so.10 However, this is not occurring in practice, possibly because many HCPs are unaware that CAM is
within their scope of practice, are uncertain of CAM evidence, lack training about CAM therapies, or are skeptical
about CAM use.10,15-18
The goal of this study was to understand why communication about CAM is not occurring between patients
and HCPs, and how CAM communication could be
improved during HCP–patient interactions. Therefore, we
examined (a) patient preferences, use, and reasons for
using CT; (b) deficiencies in patients’ access to information and information-seeking behavior; (c) HCPs’ knowledge, preparedness, opinions, and beliefs about CAM;
and (d) patient–HCP interactions, with a focus on communication about CAM.

Methods
Participants
Patients. People diagnosed with any type of cancer, aged 18
years and older, and who were attending outpatient clinic
appointments at the Tom Baker Cancer Centre were eligible
to participate. There were no restrictions on stage of disease, time since diagnosis, or treatments received.
HCPs. Health care providers of any discipline working at
the Tom Baker Cancer Centre who had contact with cancer
patients were eligible to participate. The research was
approved by the Conjoint Health Research Ethics Board of

the University of Calgary. Participation was voluntary, and
it was explained that completion of questionnaires was considered implied consent.

Procedures
Patients were approached in 2 outpatient clinics in Calgary,
Alberta. The researchers informed the patients of the purpose of the study, and those that agreed to participate were
given the option of completing the questionnaire at the
clinic, or taking a questionnaire home, and returning it
using a postage-paid envelope. Patients were only asked
about CTs, not alternative therapies. The focus on CTs was
used to avoid suggestions that the researchers advocated the
use of alternative therapies instead of conventional
medicine.
HCPs were recruited from the main cancer care hospital
in Calgary, Alberta. The HCP survey asking about CAM
was distributed via email to all HCPs. To reach as representative a sample as possible, the survey was also distributed
at various department meetings by the research team or
department heads. Hard copies of the survey were distributed to oncologists’ mailboxes.

Questions: Patients
Use of CTs. Patients were asked whether they had used CTs
since their cancer diagnosis, and if they had used CTs,
which type(s) based on the NCCIH categories. These questions were adapted from a patient needs assessment survey
designed and used within the University of British Columbia (UBC)/British Columbia Cancer Agency (BCCA) Complementary Medicine Education and Outcomes Program
(CAMEO).19 Permission for the use and modification of the
CAMEO survey was obtained.
Interest in CTs. Patients were asked to rate their interest in
learning more about each type of CT on a 5-point Likerttype scale. This question was created in order to determine
relative interest in the various categories of CTs.
Reasons for Using CTs. Patients were asked to check all reasons for their use of CTs. The options were predefined and
adapted from previous research examining CAM use in
cancer patients.12,20 Patients were also asked to indicate the
single, primary reason for their use of CTs.
Barriers to Using CTs. Eight items comprising established
barriers to CT use reported during focus groups in the
United Kingdom,21 and other barriers the researchers
hypothesized would affect patient use of CTs were presented within the questionnaire. Using a 5-point Likert-type
scale patients indicated the extent to which they found each
potential item a barrier to their use of CTs.
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CT Information Needs. Patients were asked whether they
had needed information on any of 8 listed questions about
CTs since their cancer diagnosis. These questions were replicated from the UBC/BCCA CAMEO survey.19 Furthermore, patients were asked whether they would use an
in-house hospital-based CT education program if one were
available.
Patient Perceptions of HCP Relationship. Patients were provided with 9 questions, again drawn from the UBC/BCCA
CAMEO survey,19 asking about patient–practitioner CT
communication. First, patients were asked if any HCP had
spoken to them about CTs. If patients had been spoken to
about CTs, they were asked to identify the specific HCP
who had spoken to them. The remaining 7 questions utilized a 3-point Likert-type scale to examine information
seeking, decision making, comfort, and satisfaction in relation to CT communication with the HCP.

Questions: HCPs
Knowledge About CAM. Eight questions were used to assess
knowledge of CAM and its role in cancer care. These questions came from a HCP practices and learning needs survey
designed and utilized by the UBC/BCCA CAMEO
program.19 The term CAM was used in the provider questionnaires to replicate the original instrument.19
Preparedness for CAM. Practitioners were required to rate
their CAM clinical and information seeking skills preparedness on a 4-point Likert-type scale for 10 items. Six questions assessed clinical skills whereas 4 assessed preparedness
to find credible information about CAM therapies. All questions were drawn from the UBC/BCCA CAMEO HCP
survey.19
Opinions and Beliefs About CAM. Opinions and beliefs about
CAM were obtained through 6 questions using a 5-point
Likert-type scale. The questions were adapted from a survey conducted by Visser and Peters22 on the attitudes of
Turkish general practitioners (GPs) toward alternative medicine. The questions have high internal consistency (Cronbach’s α = .86)22 and have been previously used to assess
the opinions of Canadian GPs toward alternative
medicine.23 The wording of the questions were altered from
the original22 and replaced the term “alternative medicine”
with the term “CAM.”
Perceptions About Patient Relationship and CAM. The questionnaire contained 25 questions addressing HCPs’ current
practice in the previous month. Six questions asked HCPs
about how patients were interacting with them. The following 13 questions addressed HCP interactions with patients.
Two questions asked HCP if they had directed patients to

consult with another HCP to have their questions answered
or information needs met. The next 2 questions asked HCPs
to report if they had consulted with other HCPs in order to
answer patient questions. The final 2 questions in this section asked HCPs whether they had referred patients to websites for CAM information, and to which website(s) they
referred patients. All questions were derived from the UBC/
BCCA CAMEO HCP survey.19
Interest in Further Education. HCPs were asked to indicate,
on a 5-point Likert-type scale, their interest in receiving
more information, education, and/or training about CAM.

Data Analysis
Data were analyzed using descriptive statistics and frequencies to explain the outcomes for the 2 participant groups.
Chi-squares analysis, using SPSS v21.0, examined relationships between the prevalence of various categorical variables and demographic data. Power calculations revealed a
sample size of 599 patients would provide a confidence
level of 99%, with a 5-point margin of error. A sample of
170 HCPs, out of a total population of 300, would achieve a
95% confidence level with a 5-point margin of error.

Results
Demographics
Patients. Approximately 800 cancer outpatients were
approached to participate. A total of 481 patients completed
the surveys, resulting in approximately 60% response rates.
Therefore, the final sample size is marginally underpowered, resulting in a 95% confidence interval with a 5-point
margin of error for patients. The complete demographics of
the patients are reported in Table 1. Briefly, the mean age of
the patients was 59 years, 62% were female, 78% Caucasian, diagnosed with a variety of cancer types.
HCPs. Approximately 300 HCPs were approached to participate and 100 completed the surveys, resulting in a 30%
response rate. Therefore, the final sample size is marginally
underpowered, resulting in a 95% confidence interval with
an 8-point margin of error for HCPs. The complete demographics of the HCPs are reported in Table 2.

Patients’ Use, Interest, Reasons for Use, and
Barriers to Use of CTs
Almost half of all patients surveyed (47.2%, n = 227)
reported using CTs since being diagnosed with cancer.
Biologically based therapies (74.9%, n = 170) were most
commonly used. Mind–body therapies were used by 48.5%
(n = 110) of CT-using patients, followed by energy-based

Downloaded from ict.sagepub.com at Edith Cowan University on February 8, 2016

518

Integrative Cancer Therapies 14(6)

Table 1. Demographic Characteristics of Patients (n = 481).
n
Gender
Female
Male
Ageb
58 or below
59 or above
Marital status
Single
Married
Common law
Separated
Divorced
Widowed
Education
Less than high school
High school graduate
College or technical school
Bachelor’s degree
Higher degree
Ethnicity
Caucasian
Asian
Aboriginal
Arab
Black/African American
Other
Cancer diagnoses
Breast
Gynecological
Colorectal
Brain
Prostate
Skin
Lymphoma/leukemia
Gastrointestinal
Lung
Other

%a

278
170

57.8
35.3

205
228

42.6
47.4

47
298
32
8
28
32

9.8
62.0
6.7
1.7
5.8
6.7

35
83
156
87
82

7.3
17.3
32.4
18.1
17.1

376
41
10
2
2
10

78.2
8.5
2.0
0.4
0.4
2.1

97
69
49
30
29
29
28
20
11
49

20.2
14.3
10.2
6.2
6.0
6.0
5.8
4.2
2.3
10.2

a

Value accounts for missing data.
Median age = 58 years; data recoded and split at 58.

b

CTs (34.4%, n = 78), manipulative and body-based CTs
(31.7%, n = 72), and lastly whole medical system use
(14.1%, n = 32). Fifty-three participants (23%) also reported
using other forms of CT, such as cleansing programs and
following special diets.
Significantly more females, χ2(1) = 7.1, P = .009,
younger individuals (≤58 years old), χ2(1) = 5.9, P = .016,
those with more education, χ2(6) = 21.3, P = .002, and those
who were diagnosed over a year prior to the survey, χ2(2) =
15.8, P < .001, reported utilizing CTs.
Approximately 65% of patients expressed an interest in
learning more about at least one CT. Interest was spread

Table 2. Demographic Characteristics of Health Care
Practitioners (HCPs; n = 100).

Gender
Female
Male
Age
18-34
35-49
50-64
65+
Type of HCP
Nurse
Medical oncologist
Gynecological oncologist
Pharmacist
Social worker
Psychologist/psychiatrist
Radiation oncologist
Surgical oncologist
Clinical associate
Dietitian
Radiation therapist
Unit clerk/administrative support
Other
Main area of practice
Clinical practice
Education
Research
Administration
Other
Primary cancer site
Various
Breast
Prostate
Lung
Gynecological
Head and neck
Blood
Gastrointestinal
Genitourinary
Colorectal
Skin
Central nervous system
Other

n

%a

51
20

51.0
20.0

19
26
25
1

19.0
26.0
25.0
1.0

20
8
8
7
4
4
3
2
1
1
1
1
29

20.0
8.0
8.0
7.0
4.0
4.0
3.0
2.0
1.0
1.0
1.0
1.0
29.0

64
20
16
6
2

91.4
28.6
22.9
8.6
2.9

28
23
21
21
21
19
18
17
17
15
14
13
10

40.0
32.9
30.0
30.0
30.0
27.1
25.7
24.3
24.3
21.4
20.0
18.6
14.3

a

Value accounts for missing data.

across all 5 domains, but was relatively consistent across
each type (46% to 53%). When including those patients
who reported being “neither interested nor uninterested,”
77.2% of patients may desire to learn more about CTs.
Among the 224 participants who indicated their reasons
for using CTs, the 4 most prevalent reasons were the following: to improve quality of life (QOL; 64.7%, n = 145), to
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Table 3. Health Care Practitioners’ Complementary and Alternative Medicine (CAM) Knowledge Level.
Not at All
Knowledgeable

Role of CAM in cancer prevention
Role of CAM in cancer treatment
Role of CAM in cancer symptom management
Role of CAM in cancer survivorship
Evidence to support use of CAM
Risks and benefits of CAM
Underlying principles, theory, and beliefs of CAM
Why patients use CAM

Somewhat
Knowledgeable

Knowledgeable

Very
Knowledgeable

n

%

n

%

n

%

n

%

23
24
17
29
23
20
22
12

31.1
32.4
23.0
39.2
31.1
27.0
29.7
16.2

39
37
43
35
37
40
40
34

52.7
50.0
58.1
47.3
50.0
54.1
54.1
45.9

10
13
14
10
13
14
10
21

13.5
17.6
18.9
13.5
17.6
18.9
13.5
28.4

2
0
0
0
1
0
2
7

2.7
0
0
0
1.4
0
2.7
9.5

improve immune system (54.3%, n = 121), to treat/be good
to myself (40.8%, n = 91), and to increase feelings of hope
(35.1%, n = 78). Relieving either cancer-related or treatment-related fatigue was the most common symptom for
which CT was used, reported by approximately 24% of all
patients. Forty-eight patients (21.6%) also reported that
they were using CT to cure their cancer.
The primary reason for commencing CT use was
answered by 166 patients. Most (43.4%, n = 72) revealed
that their CT use was motivated by recommendations from
family and/or friends. When questioned about their barriers
to CT use, the majority of patients reported being unsure
about the quality of evidence supporting CTs (71%, n =
245/345) and a lack of knowledge about CTs (68.6%, n =
243/354) to be barriers to their use of CTs.

The majority of HCPs reported being only somewhat or
not at all prepared when asked about CAM clinical and
information seeking skills (see Table 4). Almost 70% of
HCPs felt not at all prepared to monitor cancer patients’
CAM use and fewer than 9% of HCPs reported being very
capable of searching for credible evidence-based information on CAM and cancer.
Mixed results were also found when examining the
beliefs and opinions of HCPs toward CAM (Table 5). For
example, 49.9% (n = 36) agreed that CAM is a useful supplement to regular medicine, whereas almost 21% (n = 15)
disagreed. The most widely agreed view (66.6%, n = 48)
was that CAM includes ideas and methods from which conventional medicine could benefit.

Patient–Practitioner Relationship and
Communication About CAM

Patient CT Information Needs
The most common questions about CTs were the following:
(a) What complementary therapies can be used safely in
combination with medical cancer treatments? (36.4%, n =
175); (b) What complementary therapies are helpful for
people with cancer? (35.6%, n = 171); (c) When is it safe to
use complementary therapies after being diagnosed with
cancer? (32.6%, n = 157); and (d) Where do I find trustworthy information about complementary therapies? (32.4%,
n = 156). In response to whether or not they would use an
in-house, hospital-based CT education program, 281 of 387
(72.6%, 58.4% of the total sample) reported that they would
use such a program.

HCPs’ Current Knowledge, Preparedness, and
Opinions and Beliefs About CAM
CAM knowledge of HCPs was very limited. Between 20%
and 40% reported having no knowledge in 7 of the 8 measures reported in Table 3. The majority of HCPs reported
being only somewhat knowledgeable or not at all knowledgeable about various aspects and roles of CAM, and
almost none professed to be very knowledgeable.

The vast majority of patients (79.7%, n = 374) reported that
no HCP had spoken to them about CTs. Of those patients
who indicated they did speak to a HCP, most often this was
with either medical oncologists (40.2%, n = 43) or nurses
(40.2%, n = 43). In spite of so few patients engaging in CT
communication, more than 70% (n = 295) reported that they
were comfortable talking to their HCPs about CTs, but only
28.8% (n = 99) of patients agreed that their HCP had listened to what they had to say. Overall, only 55 (16%)
patients felt that they had received enough information
about CTs from cancer health care professionals (Table 6).
A significant relationship was found between information and support-seeking and the information and support
received. Significantly more patients who requested CT
information from their HCPs felt that they received enough
CT information, χ2(4) = 139.2, P < .01, and that they
received enough support in making decisions about CTs,
χ2(4) = 73.1, P < .01. Similarly, significantly more patients
who requested CT decision-making support from their
HCPs felt that they had received enough CT information,
χ2(4) = 139.2.1, P < .01, and that they had received enough
support in making decisions about using CTs, χ2(4) = 157.1,
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Table 4. Health Care Practitioners’ (HCPs’) Levels of Preparedness Regarding Complementary and Alternative Medicine (CAM)
Clinical Skills and CAM Information Seeking.
Not at All
Prepared

Clinical skills
Assess patients’ use of CAM
Assist patients in disclosing CAM use to HCPs
Assist patients in making decisions about CAM
Talk to patients who want to use CAM instead of conventional treatment
Respond to patient requests for specific CAM recommendations
Monitor cancer patients’ use of CAM
Information seeking skills
Find credible CAM information resources
Identify the credibility of CAM information resources
Search for evidence about CAM
Critique evidence about CAM

Somewhat
Prepared

Very
Prepared

Prepared

n

%

n

%

n

%

n

%

27
23
25
29
31
50

37.0
31.9
34.2
39.7
42.5
68.5

31
30
36
30
30
21

42.5
41.7
49.3
41.1
41.1
28.8

12
14
10
10
11
1

16.4
19.4
13.7
13.7
15.1
1.4

3
5
2
4
1
1

4.1
6.9
2.7
5.5
1.4
1.4

20
28
21
22

27.8
38.9
29.2
30.6

36
28
30
30

50.0
38.9
41.7
41.7

12
12
15
15

16.7
16.7
20.8
20.8

4
4
6
5

5.6
5.6
8.3
6.9

Table 5. Health Care Practitioner Endorsement of Opinions and Beliefs About Complementary and Alternative Medicine (CAM).
Strongly
Disagree

CAM is a threat to public health
Treatments not tested scientifically should be discouraged
CAM is a useful supplement to regular medicine
Results from CAM are usually due to a placebo effect
Most CAM stimulates the body’s natural therapeutic powers
CAM includes ideas and methods from which conventional
medicine could benefit

Neither Agree
nor Disagree

Disagree

Agree

Strongly
Agree
n

n

%

n

%

n

%

n

22
7
2
8
7
3

30.6
9.7
2.8
11.1
9.7
4.2

21
8
13
23
12
3

29.2
11.1
18.1
31.9
16.7
4.2

25
28
21
30
33
18

34.7
38.9
29.2
41.7
45.8
25.0

3
24
25
9
12
33

%

4.2 1
33.3 5
34.7 11
12.5 2
16.7 8
45.8 15

%
1.4
6.9
15.2
2.8
11.1
20.8

Table 6. Patient Perceptions of Communication With Health Care Practitioners (HCPs).
Neither Agree nor
Disagree

Agree
n
I am comfortable talking to HCPs about complementary therapies (CTs)
HCPs listened to what I had to say about CTs
I requested information about CTs
HCP connected me with someone who provided CT information
I received enough information about CTs
I requested support in making decisions about CTs
I received enough support in making decisions about CTs

P < .01. In addition, significantly more of those patients
who felt their HCP listened to them about CTs were comfortable in discussing CTs, χ2(4) = 88.2, P < .01, requested
information about CTs, χ2(4) = 498, P < .01, and felt that
they had received enough CT information, χ2(4) = 82.3, P <
.01, and CT decision-making support, χ2(4) = 75.5, P < .01.

295
99
46
39
55
48
49

Disagree

%

n

%

n

%

70.9
28.8
12.7
11.3
15.9
14.2
14.4

80
206
167
146
141
135
172

19.2
42.8
46.0
42.2
40.9
40.1
50.4

41
39
46
161
149
154
120

9.9
11.3
12.7
46.5
43.2
45.7
35.2

HCP Perceptions
To complement patient reports, HCPs were asked how
patients were interacting with them about CAM. Just over
70% (n = 61) of HCPs indicated that at least one patient had
told them about CAM use in the past month. On average,

Downloaded from ict.sagepub.com at Edith Cowan University on February 8, 2016

521

King et al
HCPs reported that roughly 1 in every 5 (23.3%) patients
was telling them about CAM use. Moreover, 50 (58.1%)
HCPs reported a similar ratio (21.1%) of patients seeking
advice about a CAM therapy that they were currently using.
It was less common for HCPs to be asked to monitor patient
use of a CAM therapy (12.3%, n = 11), or refer patients to a
CAM service or CAM practitioner (15.1%, n = 13).
HCPs were also asked about how they were interacting
with patients about CAM. Close to 63% (n = 50) of HCPs
reported asking patients about their use of CAM. Nearly
half (45%, n = 36) of HCPs provided patients with recommendations about a CAM therapy, while only 8.8% (n = 7)
of HCPs were monitoring a patient’s use of CAM and even
fewer (6.3%, n = 5) were providing a CAM therapy to
patients. Close to a third (32.5%, n = 26) of HCPs reviewed
CAM evidence with patients and 25.0% (n = 20) provided
patients with CAM educational materials. Very few HCPs
(11.5%, n = 9) referred patients to websites for CAM information. A greater proportion of HCPs (49.5%, n = 39) had
suggested a patient discontinue a CAM therapy than had
suggested a patient use a CAM therapy (32.9%, n = 26).
Of those HCPs who had suggested a patient discontinue
a CAM therapy, antioxidants (especially when on radiation
therapy), herbs, and high-dose vitamins were the therapies
most often advised against. The main reasons practitioners
suggested CAM therapy discontinuation included theoretical concerns of interaction (92.3%, n = 36), literature evidence of interaction/harm (46.2%, n = 18), no evidence of
efficacy (43.6%, n = 17), and personal clinical experience
of interaction/harm (12.8%, n = 5).
HCPs who suggested patients use a CAM therapy most
often suggested mind–body therapies and acupuncture.
Practitioners based these suggestions mainly on positive
effects seen in other patients (73.1%, n = 19), literature evidence of benefit (65.4%, n = 17), and personal clinical
experience of benefit (57.7%, n = 15).
By their own admission, most HCPs believed that they
required further education and/or training about CAM for
cancer care. When surveyed, 90% (n = 63) reported being
interested (44.3%, n = 31) or very interested (45.7%, n =
32) in receiving additional CAM training. Only 31.4% (n =
22) of HCPs reported having already received some CAM
training, predominantly in the form of conference presentations, through a hospital in-service program, and from seminars/lectures in medical school.

Discussion
This study explored patients’ use, interest, and informationseeking behavior around CTs as well as HCPs’ knowledge,
opinions, and beliefs and revealed some interesting discrepancies between the perceptions of patients and those of their
HCPs. For example, many patients reported that HCPs did
not discuss CT use with them, but a greater proportion of

HCPs felt they had. Other unique findings discussed below
explore communication between patients and HCPs, patient
needs for information and decision support, as well as training needs of HCPs.

Patients’ Use, Interest in Use, Reasons for Use,
and Barriers to Use of CTs
Similar to previous reports,5 47.2% of patients reported using
CTs since cancer diagnosis, biologically based and mind–
body therapies were most popular, and CT use was higher
among females, younger individuals, and those with greater
education.7-9 Individuals who were at least 12 months post
diagnosis were more likely to report using CTs. This finding
suggests that CT use changes over the cancer trajectory,
which supports previous findings that identify the influence
of disease status as well as psychological social, cultural, and
other factors, such as patient–provider communication on CT
use.10,24,25 At the time of diagnosis, many patients are interested
in taking stock of the full range of conventional and CT treatment options, requiring open, unbiased, and purposeful communication about CTs and CT decision support by HCPs.
Complementary therapy decisions and use has been shown to
shift over the cancer trajectory, particularly at times of transition, such as at the end of primary treatment, or when disease,
social, or other contextual factors shift.10 These transition are
also key points for interaction and communication with HCPs
about CTs to ensure patients’ CT information and decision
support needs are met.26
Consistent with previous research, the most common
reason patients reported using CTs was to improve their
quality of life.12,20,27 Research also suggests that patients use
CAM for other beneficial effects and to play an active role
in their treatment,9,10 which was echoed in the present study.
Patients were using CTs as a form of symptom management, to reduce cancer and treatment-related fatigue and to
improve their immune system. CT use was also employed
as a means of improving emotional well-being with patients
reporting CT use to be good to themselves or to improve
feelings of hope.
Surprisingly, just over 1 in 5 patients indicated using CTs
to cure their cancer. This underscores the need for greater
patient education about CTs to reduce misperceptions and
reinforce the necessity of using CTs as an adjunct to conventional medicine, not as an alternative.
When asked about their primary reason for initiating CT
use, most patients reported that they began due to recommendations from family or friends. This finding replicates
previous research, as did the finding that few patients began
using CTs due to HCP recommendation.11,12 Though family
and friends are well intentioned, it is concerning that they
are the primary motivators for uptake of CT as the information provided may be inaccurate or not account for potential
adverse effects the CT could present to the patient. This
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finding is surprising since the largest barriers to CT use
were either being unsure about the quality of evidence supporting CTs and a lack of knowledge about CTs. The lack of
HCP-initiated communication about CTs (80% of patients
reported no HCP had asked them about CT use) may deter
patients raising this subject further. However, it is also possible that patients choose not to tell their HCPs about their
CT use, thus eliminating any role, be it positive or negative,
that their HCP may have in their use of CTs. Despite concerns about the impact CTs may have on their health and
wanting to be informed about safety and effectiveness of
CTs, patients do not appear to be sufficiently engaged with
HCPs. Therefore, the availability of evidence-based patient
resources to increase patients’ knowledge of CTs would
likely enable patients to be better prepared to make informed
decisions about using CTs.

HCPs’ Knowledge, Preparedness, Opinions and
Beliefs, and Interest in Further Education About
CAM
Congruent with previous studies,15,16,28 HCPs reported little
knowledge about CAM. Similarly, HCPs felt relatively
unprepared to address CAM in a clinical context, or to find
and evaluate information about CAM. These findings are
concerning as patients either already are or should be turning to their HCPs for advice and guidance about comprehensive cancer care, including CAM. A lack of knowledge
about CAM limits a HCP’s ability to provide patients with
accurate and supportive advice. Moreover, if practitioners
are not prepared to assess and monitor CAM use, or provide
specific CAM recommendations and guidance, this is likely
to negatively affect the patient–practitioner relationship and
cancer-related outcomes. Previous research has demonstrated that when HCPs do not engage patients or are perceived as unwilling or unprepared to discuss CAM, this can
impair the overall patient–HCP relationship.18,26 This lack
of communication about CAM may place patients in a situation where they are required to independently make CAM
decisions as well as self-monitor their CAM use. Lack of
guidance and support for HCPs about CAM may lead to
unintended patient self-harm and/or interfere with expected
conventional treatment outcomes.26
Also concerning was that many HCPs reported being
unprepared to evaluate whether information was credible or
suitable for their patients (Table 4). In general, HCPs have
training in information seeking and evaluation, so this result
may be related to the complexities and unfamiliarity of
CAM literature for these professionals. Only a third of
HCPs reported having received any CAM training; this lack
of training may explain practitioners’ deficiencies in CAM
knowledge and preparedness, highlighting the need for further education to improve competencies in these areas.

HCPs acknowledged the need to learn more about CAM.
It was found that 90% of practitioners reported interest in
receiving further CAM education. This interest is consistent
with practitioners’ efforts to address CAM needs for patients
reported by others.15,16 Furthermore, it is known that
increasing CAM training leads to an increase in CAM recommendations, improves patient–practitioner communication about CAM, and creates more positive and open
attitudes toward CAM.29

Patient–Practitioner Perceptions and
Communication
Patients and HCPs were asked several questions about the
type and quality of communication that was occurring. The
findings in this area were generally not consistent, and did
not always reflect positively on the overall relationship. It is
possible that HCPs and patients hold different perceptions
of what “speaking to” and “being spoken to” about CTs
consists of. Patients may be expecting a more in depth discussion of CTs than HCPs are offering, or the timing of the
discussions initiated by HCPs may not align with when
patients are most receptive to hearing or engaging in them.
The discrepancy may also be explained by the large proportion of patients who were diagnosed with cancer for a year
or less. As reported above, patients in this study were more
likely to use CTs with increasing time since diagnosis and,
therefore, the practitioners may have been more focused on
conventional and curative treatment and not yet have had a
chance to speak to patients in the early stages of their cancer
care journey about CTs.
A notable discrepancy existed between HCPs’ reports of
their current practice around CTs and patients’ reports of
communication about CTs. The findings from the patients
in this study suggested that HCPs are not adequately
addressing their needs or providing sufficient information
and support about CTs. In contrast, two thirds of practitioners reported asking patients about their use of CAM, which
could provide a doorway for further discussion. The difference in results between patients and practitioners may be
explained by the sample of HCPs being examined. The
HCPs who responded to this questionnaire may have been
more interested in CTs and thus a more involved and
informed subsample of practitioners.
Nonetheless, it is apparent that the majority of patients
are not discussing CTs with their HCPs, even though
patients are willing to discuss their CAM use and are turning to their practitioners for advice and guidance. Patients
trust their HCPs21 and want them to play a role in determining how and when CAM therapies are used. Patients expect
that HCPs will initiate discussions of CTs10 and have cited
in the past “not being asked about CTs” as a reason for nondisclosure of their use.27 The lack of HCP-initiated CT
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discussions is concerning for a number of reasons, particularly the potential for negative impact on patient health.
HCP results suggested that patients are increasingly initiating discussions of CTs. Over two thirds of HCPs indicated that a patient had told them about their CAM use. This
is a positive finding as patient disclosure of CAM use has
been associated with patient-centered communication,
which in turn has been shown to enhance satisfaction with
care, reduce distress, and improve conventional treatment
adherence.26,30,31 On average, a quarter of the patients seen
by practitioners were reporting their CAM use to HCPs; a
similar proportion has been reported in previous studies.32
This figure reveals that three quarters of patients are not
self-disclosing their use of CAM to their practitioners, once
again highlighting the need for HCPs to initiate CAM
discussions.
In contrast, almost half of the HCPs indicated that they
provided recommendations about CAM to their patients.
Practitioners suggested more often that patients discontinue, as opposed to commence CAM. Initiating CAM was
only suggested on the basis of research evidence or personal
clinical experience displaying beneficial effects. However,
almost all practitioners reported that they would suggest
discontinuing CAM based on theoretical concerns about
interactions with conventional medicine. This was often
supplemented with evidence of harmful interactions or lack
of efficacy. In general, HCPs required a higher standard of
proof to recommend CT than they needed to remove it. This
practice ensures patient safety and is complimented by
research demonstrating that HCPs are not willing to recommend CAM that is not backed by scientific evidence.15

Limitations
Some limitations should be considered when interpreting
the findings of this study. The response rate of 30% for
HCPs limits the generalizability of these findings, and
raises questions about whether the overall positive view of
CAM is a true representation or if self-selection bias
affected the opinions and beliefs of HCPs. This bias may
have led to practitioners who hold more positive views of
CAM to participate. Reasons for nonparticipation were not
recorded and, therefore, it is not possible to determine
whether HCPs withdrew due to a lack of interest or knowledge of CTs.
The response rate of 60% was far greater for the patients;
however, the generalizability of the results is also affected
by the fact that a large proportion of patients were diagnosed less than 12 months previously. Therefore, findings
may not be applicable to individuals with more chronic cancers or long-term cancer survivors.
A final limitation of the study, faced by all research in
this area, is the broad definition of CAM and the large
number of therapies it encompasses. Both the patient and

HCP questionnaires addressed this issue by using standardized definitions. The patient questionnaire further
addressed the issue by using examples of CTs and asking
patients about CTs in general, the 5 categories of CTs, and
to list the specific CTs they utilized. The HCP questionnaire was less successful at addressing the variety of therapies and products encompassed by CAM as it only asked
about CAM as a whole. Several HCPs commented that
their practice, knowledge, skills, opinions, and beliefs
varied based on the CAM therapy or product being
discussed.

Conclusions
In summary, almost half of the cancer patients surveyed had
utilized CTs since their diagnosis. Patients report that HCPs
are not communicating with them about CTs and that their
CT information and decision-making needs are not being
met. However, when communication occurs, it appears to
be effective in satisfying patient concerns. Patients are
interested in learning more about CTs, specifically the
impact on their health, and would utilize a hospital-based
education program to obtain this knowledge. In contrast,
HCPs reported a greater incidence of patient-initiated communication about CAM and also report more practitionerinitiated communication than patients did. HCPs are
cautious in the recommendations they make about CAM,
making more recommendations toward discontinuation of
CAM. Similar to patients, HCPs were interested and willing
to receive more education and training in CAM.
There is a clear need for improved education and training materials and programs for both patients and HCPs.
Such materials and training will help ensure HCPs are
meeting patients’ CT needs. It will also help guarantee that
patients are receiving reliable and accurate information
about CTs and guidance that will allow for CTs to be used
to improve their health and well-being, while avoiding the
potentially harmful impact of inappropriate CT use. Finally,
increased education and training about CTs will move cancer care toward providing a more integrative form of oncology that will allow patients to have all of their care and
information needs to be met at a single location.
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